| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |